Australia's medicine regulator has identified a second case of rare blood clots believed to be linked to the AstraZeneca vaccine. The blood clots affected a woman aged in her 40s who was vaccinated in Western Australia. Head of the Therapeutic Goods Administration Professor John Skerritt says despite the latest case, he wants to reassure people the odds of the rare blood clot remain low. The federal government has decided against buying the Johnson and Johnson coronavirus vaccine to boost the nation's immunisation rollout. Health Minister Greg Hunt has ruled out proceeding with the purchase at this stage because it is too similar to the AstraZeneca drug.


